Trials / Completed
CompletedNCT07334886
A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)
A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]Ulonivirine in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn how \[14C\]ulonivirine moves through a healthy person's body over time. Researchers will study how \[14C\]ulonivirine is absorbed by the body, broken down by the body, and how it leaves the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]Ulonivirine | Oral Solution |
Timeline
- Start date
- 2025-09-17
- Primary completion
- 2025-11-11
- Completion
- 2025-11-11
- First posted
- 2026-01-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07334886. Inclusion in this directory is not an endorsement.